Skip to main content
Skip to section navigation
Skip to footer
866.776.5907
Glassdoor
Linkedin
Twitter
YouTube
Header Utility
Client Services
Specimen Kits
Online Orders
Requisition Forms
About
Events
Molecular Tumor Board
Trade Shows
Webinars
Diagnostic Symposiums
Newsroom
Blog
Press Releases
Literature
Podcast
Videos
Our Team
Employee Benefits
Investors
NeoUniversity
Corporate Stewardship
Regulatory
Good Faith Estimate
Privacy
Terms of Use
Billing
Patients
Third Party Billing
Careers
Contact
NeoLINK Login
Main navigation
Diagnostic Services
Methodologies
Anatomic Pathology
Cytogenetics
FISH
Flow Cytometry
NGS
Sponsored Testing Programs
FOLR1 Ovarian Cancer Testing Program
KRAS Single Gene Test Program
Tech-Only Program Services
Laboratory Collaboration
Specialty Testing
Neo Comprehensive - Heme Cancers
Neo Comprehensive - Solid Tumor
COMPASS®
CancerTYPE ID®
Hereditary Cancer
InVisionFirst®-Lung Liquid Biopsy
Liquid Biopsy
NeoTYPE®
Early-Stage NSCLC Panel
Pharma Services
Why Choose NEO
Expertise
CDx Services
Project Requirements and Compliance
Lab Services
Anatomic Pathology
Molecular
Multiplexed Immunofluorescence
Flow Cytometry
FISH & Cytogenetics
CAR-T Services
Informatics & Data Solutions
Patients
Billing
In-home Blood Draws
Testing Terminology
Testing Methods and Tumor Profiling
Sponsored Testing Programs for Patients
Frequently Asked Questions
InVisionFirst®-Lung (Liquid Biopsy)
Test Menu
Search
Mobile Nav
Presentations
Investor Relations
News & Events
Presentations
Investor Relations
Investor Relations
Overview
News & Events
Press Releases
IR Calendar
Presentations
Literature
Email Alerts
Company Info
Overview
Executive Team
Tear Sheet
FAQ
Financial Info
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Info
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
ESG Report
Nov 5, 2024
NeoGenomics Investor Presentation – November 2024
rss_feed
RSS
Accessibility statement
Email alerts
Company profile
RSS news feed
Search
Main navigation
Diagnostic Services
Methodologies
Anatomic Pathology
Cytogenetics
FISH
Flow Cytometry
NGS
Sponsored Testing Programs
FOLR1 Ovarian Cancer Testing Program
KRAS Single Gene Test Program
Tech-Only Program Services
Laboratory Collaboration
Specialty Testing
Neo Comprehensive - Heme Cancers
Neo Comprehensive - Solid Tumor
COMPASS®
CancerTYPE ID®
Hereditary Cancer
InVisionFirst®-Lung Liquid Biopsy
Liquid Biopsy
NeoTYPE®
Early-Stage NSCLC Panel
Pharma Services
Why Choose NEO
Expertise
CDx Services
Project Requirements and Compliance
Lab Services
Anatomic Pathology
Molecular
Multiplexed Immunofluorescence
Flow Cytometry
FISH & Cytogenetics
CAR-T Services
Informatics & Data Solutions
Patients
Billing
In-home Blood Draws
Testing Terminology
Testing Methods and Tumor Profiling
Sponsored Testing Programs for Patients
Frequently Asked Questions
InVisionFirst®-Lung (Liquid Biopsy)
Test Menu
Search
Header Utility
Client Services
Specimen Kits
Online Orders
Requisition Forms
About
Events
Molecular Tumor Board
Trade Shows
Webinars
Diagnostic Symposiums
Newsroom
Blog
Press Releases
Literature
Podcast
Videos
Our Team
Employee Benefits
Investors
NeoUniversity
Corporate Stewardship
Regulatory
Good Faith Estimate
Privacy
Terms of Use
Billing
Patients
Third Party Billing
Careers
Contact
NeoLINK Login
Phone number
Glassdoor Icon
Linkedin Icon
Twitter Icon
YouTube Icon
Search
